Vasculitis Trial, Recruiting NCT05437965 Sponsor: China National Center for Cardiovascular Diseases Condition: Vasculitis
Back to Vasculitis

Vasculitis Trial, Recruiting

NCT05437965
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with a specific condition called RECUR, which involves repeated, unexplained narrowing returning inside a coronary stent (a small tube placed in a heart artery)
  • You have been fully informed about what the trial involves and are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • You have a serious illness (such as cancer or severe heart failure) that means your life expectancy is less than 12 months
  • You have a known autoimmune or inflammatory condition such as lupus, rheumatoid arthritis, Behçet's disease, Takayasu arteritis, or a similar disease affecting the immune system or blood vessels (confirm with trial site if unsure whether your condition qualifies)
  • You have a type of chest pain caused by artery spasms, known as Prinzmetal's or variant angina
  • You have a tear in a coronary artery (coronary artery dissection)
  • You have a blood clotting disorder (thrombophilia)
  • Your stent was not fully expanded when it was placed
  • You have a psychiatric (mental health) disorder
  • It is known that you would not be able to complete all the required follow-up visits for the trial, for any reason
  • The trial doctor has determined for any other reason that you are not suitable to join

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 008613910008985

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
China National Center for Cardiovascular Diseases
Registry
ClinicalTrials.gov
Start date
3 June 2020
Est. completion
1 April 2035

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Target vessel failure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov